{"nct_id":"NCT03363841","title":"Open-Label Study to Evaluate the Efficacy and Safety of Oral Ibrexafungerp (SCY-078) in Patients With Candidiasis Caused by Candida Auris (CARES)","status":"COMPLETED","status_verified_date":"2024-06","start_date":"2017-11-15","start_date_type":"ACTUAL","primary_completion_date":"2023-04-14","primary_completion_date_type":"ACTUAL","completion_date":"2023-05-24","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["SCYX"]}